ArticleMedical journal, Armed Forces India2021

Open-label randomized control trial of hydroxychloroquine in patients with moderate to severe coronavirus disease 2019 infection.

Salil Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.